newsfilter
← Latest News
Business Wire·

4D Pharma Announces Positive Topline Results From Part a of Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma

Part A of the study meets primary endpoint of safety and tolerability Achieved multiple key secondary endpoints relating to improved asthma control compared to placebo 4D pharma plc ((AIM: DDDD, NASDAQ:LBPS), a pharmaceutical company leading the d